Ripple submits a motion to seal and amend parts of the SEC lawsuit documents
On May 14th, Ripple submitted a motion before the deadline on May 13th, requesting a narrow revision of briefs and certain evidence related to the relief motion. The company stated that its sealing request is reasonable and consistent with the sealing requests approved by the court at the summary judgment stage of litigation. Before submitting this motion on Monday, Ripple's lawyers consulted with U.S. financial regulators. The U.S. SEC indicated that it accepts some of Ripple's requests and may object to others. According to documents, Ripple attempts to edit information that could harm the company, innocent third parties, and Ripple employees if disclosed publicly; seeking a narrow revision for its audited financial statements and related documents.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment
According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.
After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.
Crypto prices
More
